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Abstract: Konzo is a distinct neurological entity with
selective upper motor neuron damage, characterized by
an abrupt onset of an irreversible, non-progressive, and
symmetrical spastic para/tetraparesis. Despite its severity,
konzo remains a neglected disease. The disease is
associated with high dietary cyanogen consumption from
insufficiently processed roots of bitter cassava combined
with a protein-deficient diet. Epidemics occur when these
conditions coincide at times of severe food shortage. Up
to 1993, outbreaks in poor rural areas in Africa contrib-
uted to more than 3,700 cases of konzo. The number of
affected people is underestimated. From unofficial re-
ports, the number of cases was estimated to be at least
100,000 in 2000, in contrast to the 6,788 cases reported up
to 2009 from published papers.
Introduction
Konzo is a distinct neurological entity with selective upper
motor neuron damage, characterized by an abrupt onset of an
irreversible, non-progressive, and symmetrical spastic para/
tetraparesis [1–8].
The disease is associated with prolonged high dietary cyanogen
consumption from insufficiently processed roots of bitter cassava
combined with a protein-deficient diet low in sulphur amino acids
(SAAs) [1–8].
Since its first description by the Italian doctor Trolli eight
decades ago in the former Belgian Congo (now the Democratic
Republic of Congo [DRC]), epidemics have been reported from
many cassava-consuming areas in rural Africa. Up to 1993, the
total of reported cases was approximately 3,700 to 4,000 [9–11].
Konzo remains a health problem in Africa. Since 1993, the
disease has extended beyond its first reported boundaries [12], and
the reported number of konzo cases has almost doubled, reaching
a total of 6,788 (Table 1, Figure 1).
Outbreaks in past decades in Cameroon [12], Mozambique
[13,14], Tanzania [15], the Central African Republic [16], and
the DRC [17,18] often received insignificant attention from the
media and local health authorities despite the clinical severity of
konzo. As in the earlier reported outbreaks, poverty in association
with agricultural crises provoked by drought or war was a constant
feature. Those affected belonged to the poorest segments of the
most remote rural areas of Africa, perpetuating the silence around
the disease.
Cassava is also an important source of food in the tropics
outside of Africa [19], and, although remote, the possibility of
konzo occurring in these areas should be considered. Another
disease associated with chronic cassava consumption, tropical
ataxic neuropathy (TAN), has been described recently in India
[20]. The same socioeconomic factors implicated in konzo were
present, and in some cases, patients had clinical features
compatible with konzo.
Lessons from the previous outbreaks indicate that the number of
people affected by konzo is underestimated. Unofficial reports point
to an alarming number of 100,000 cases in the DRC in 2000 [21].
Examples from the past confirm that the disease can be easily
overlooked. In the 1986 Zaire (now DRC) epidemic, the actual
number of cases was estimated to be at least twice as many as those
reported [22]. In Mozambique, in 1981, during a severe drought,
an outbreak of more than 1,000 cases of konzo occurred, and was
associated with an almost exclusively cassava-based diet. The
disease, locally named ‘‘Mantakassa’’, was restricted to the remotest
areas of the isolated northern province of Nampula. The extent of
the epidemic was only revealed after an extensive 2-month active
case detection exercise [23]. Nonetheless, cases were missed, and
further research carried out by the authors found that the epidemic
extended beyond its previously reported boundaries [14].
Cultural and religious aspects may also play a role in
underreporting, particularly in sporadic cases of konzo. In the
Congo, ‘‘konzo’’ was the name of a fetish used with traps to catch
wild animals by weakeningtheir legs and preventing their escape. In
man, the appearance of konzo was interpreted as a kind of divine
punishment or sorcery caused by improperly using the fetish [6].
Sporadic cases of konzo can be misdiagnosed if health care staff
are not trained to recognize the symptoms. In 1981, in
Mozambique, the disease was initially considered to be of viral
origin [23]. In the DRC, a community-based survey revealed that
cases of acute paraparesis initially attributed to poliomyelitis were
in fact cases of konzo in the context of an outbreak [17].
The possibility of an infectious agent was considered in the early
reported epidemics, particularly HTLV-I-associated myelopathy/
tropical spastic paraparesis (HAM/TSP). Cerebrospinal fluid
studies were, however, normal, and serology for the retroviruses
(HIV or HTLV-1) implicated in progressive spastic myelopathy
was negative [2,8,23–25].
In an era of climate transformation and continued insecurity, it
is important to keep in mind the possibility of new epidemics of
konzo in vulnerable areas, particularly in Africa. We therefore
review the disease, from aetiology to clinical evolution.
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We aimed to provide a non-systematic review of konzo, using
published and unpublished sources. For published literature, we
first searched the Medline database using the search terms ‘‘konzo
and cassava’’, ‘‘konzo and cyanogen’’, ‘‘konzo and cyanide’’, and
‘‘spastic paraparesis and cassava’’. This search yielded 52 articles.
We then searched the Agricola database using the search term
konzo, and obtained 15 articles. We reviewed all these published
articles, three PhD theses on konzo, and a further 25 articles
identified by reference review.
From Poverty to Cyanogen Intoxication
Monotonous Diet Based on Cassava
Cassava (Manihot esculenta Crantz) is a perennial 1–3 meter
high tropical shrub. The leaves have a high content of protein
and vitamins, and normally they are consumed after processing,
which removes cyanogens. The major harvested organ is the
root. The roots have a high content of carbohydrate and also
small amounts of some vitamins and minerals. Their protein
content is low and deficient in SAAs such as cystine and
methionine [26–28].
From 1965 to 2000, cassava cultivation in Africa showed an
extraordinary increase, from 35 million to 90 million tons, at
least partly in response to declining soil fertility and increased
cost of inorganic fertilizers. For countries such as DRC,
Tanzania, and northern Mozambique, cassava is the most
important crop for the largest proportion of farming households
[29–31]. The amount of labour required for cassava cultivation is
considerably less than that for other crops, and this is a major
reason for its promotion and increasing use in HIV/AIDS-
affected communities [32].
Cassava is drought tolerant, grows on poor soils without
fertilizer where no other staple can be cultivated, and generates
acceptable yields even on depleted and marginal lands. Its roots
may be kept in the soil for extended time periods, securing a
carbohydrate source in years of agricultural crisis in poor
communities, and bridging the seasonal food gap during the
hungry and dry season when other crops usually fail [31,33].
It is no surprise that in times of agricultural crisis, cassava
becomes the dominant, and sometimes the only, source of food.
Cassava and Cyanogen Consumption
Many species of plants liberate hydrogen cyanide from
cyanogenic glycosides (CGs), a phenomenon called cyanogenesis,
as a defense mechanism against animals and marauding insects
[34,35]. Cassava is by far the most important human food source
that uses cyanide as a defense mechanism [35].
Roots and leaves of cassava of all varieties contain CGs, mainly
as linamarin, but also as lotaustralin, in different concentrations in
their cellular vacuoles [34,36].
Cyanogenesis is initiated in cassava when the plant tissue is
damaged. Linamarase, a cell wall enzyme, is necessary for
production of acetone cyanohydrin (AC) from the hydrolysis of
linamarin (Figure 2). AC in cassava flour is unstable and can
decompose to acetone and hydrogen cyanide spontaneously at
pH.5.0 or at elevated temperatures (above 35uC), or enzymat-
ically due to the action of hydroxynitrile lyase [34–37]. In gari, a
commonly consumed cassava product, AC is quite stable at
pH 4.2 at 50uC, and even at 100uC it is only slowly removed, and
can only be removed if pH is raised to around 5 [38].
The concentration of CGs depends on both genetic and
environmental factors. Water stress increases CG concentration,
and agro-ecological differences can influence the cyanogenic
potential of the same cassava cultivar [39,40].
CGs in cassava can be reduced by appropriate processing of the
plant material prior to consumption. Processing also improves
palatability and increases shelf life, as the root suffers rapid post
harvest deterioration if preserved in the fresh state for more than a
few days [41,42]. The final product may be flour (tapioca) or
granules (gari).
High dietary cyanogen exposure occurs when high cyanogenic
cassava and insufficient cassava processing are combined, usually
in a context of food shortage.
In konzo-affected areas, insufficient cassava processing is
attributed to short cuts in the established methods and is related
to food shortage due to drought, crop failure, and sometimes
commercialization of cassava [9]. Water stress may also increase
the CG concentration in cassava to a level where the traditional
processing methods can no longer avoid high retention of
cyanogens [43,44].
Cassava roots are processed by a variety of methods, depending
on factors such as traditional preferences, time taken, and the
availability of water and technology. Common methods used in
Africa include soaking, sun drying, heap fermentation, and grating
plus roasting [30,42]. Mechanical disruption of plant cells during
these processes allows a cyanogenesis reaction (Figure 2) to
proceed, and thus CGs are eliminated in different degrees.
A new, feasible, and simple method, the ‘‘wetting method’’, may
be used for cassava flour, and decreases substantially the cyanide
content [45]. This method has been successfully tested and
accepted in rural communities in Mozambique and Tanzania,
where water is in short supply and sun drying and heap
Table 1. Total number of konzo cases reported up to 2009.
Country Prior to 1975 1975–1993 1994–2009 Total
Democratic Rebublic of
Congo
1,237 919 1,303 3,459
Mozambique 2,123 281 2404
Tanzania 121 238 359
Central African Republic 16 81 97
Cameroon 469 469
Total 1,237 3,179 2,372 6,788
Adapted from [9].
doi:10.1371/journal.pntd.0001051.t001
Key Learning Points
N Konzo is a neurological entity found in Africa character-
ized by an abrupt onset of an irreversible, non-
progressive, and symmetrical spastic para/tetraparesis.
It affects the poorest people from the remotest areas in
the continent.
N Poverty is the main risk factor, and commercialization,
drought, or wars are the usual precipitators.
N The number of cases is probably underestimated; the
disease continues to be reported and is expanding to
new areas of the continent.
N The epidemics are associated with prolonged high
dietary cyanogen consumption from insufficiently pro-
cessed roots of bitter cassava combined with a protein-
deficient diet low in sulphur amino acids.
www.plosntds.org 2 June 2011 | Volume 5 | Issue 6 | e1051fermentation are common processing methods [46–48]. In the
DRC, where soaking is the prevalent method [3], a trial recently
showed that the wetting method was acceptable, but the final
results are still to be evaluated [48].
High cyanogen consumption is an endpoint of preventable
factors acting in sequence or synergistically in the pre-pathogenic
phase of konzo (Figure 3).
Cyanogen Toxicity and Konzo
The association between the occurrence of konzo and high
consumption of improperly processed cassava has been described.
In all major epidemics the appearance of konzo has been
associated with a sustained and sub-lethal intake of cassava high
in CG concentration in combination with a low SAA intake
[1–8,12–18].
The neurotoxic mechanism is not yet clarified and the existent
neuropathological or imaging studies have not revealed any
particular abnormality [4,5,49]. Neurophysiological studies in
konzo point to involvement of either the corticomotorneurons or
the descending motor pathways [5,49].
Although several compounds have been proposed as candidates
for the neurotoxic agent in konzo, few experimental studies
involving those candidates have been reported. Table 2 summa-
rizes the results of the principal experimental studies that have
been carried out to date. The closest human model for konzo
comes from primate experiments [55]. These have shown that the
clinical and pathological findings in the central nervous system
secondary to cyanate exposure are compatible with konzo.
Cyanide, a mitochondrial oxidative phosphorylation blocker
[56], is the first described candidate for neurotoxicity in konzo
Figure 2. The cyanogenesis reaction.
doi:10.1371/journal.pntd.0001051.g002
Figure 1. Countries in Africa where konzo has been reported.
doi:10.1371/journal.pntd.0001051.g001
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blood cyanide and konzo [4,57].
Cyanide comes from the conversion of linamarin, but we do not
know where this happens most. Processing causes some conversion
to AC, which probably decomposes to cyanide in the high pH of
the gut [7,9].
Cyanide is also absorbed through skin or the respiratory tract
and is rapidly distributed throughout the body. Highest levels are
typically found in the liver, lungs, blood, and brain [58].
Rhodanese is the enzyme responsible for most cyanide
detoxification, transforming it to thiocyanate, which is subse-
quently excreted in the urine. The enzyme is located in all tissues,
but mainly in the liver. This process requires sulphur donors,
provided from dietary SAAs, which are deficient in cassava roots
[58,59].
The capture of cyanide with the iron in the erythrocytic
haemoglobin to form methaemoglobin is an important temporary
measure to keep the cyanide under control. Other mechanisms,
such as capture with hydroxycobalamin (vitamin B12a) to yield
cyanocobalamin (vitamin B12), provide no practical contribution
to reducing its toxic effects [58,59].
The evidence for the association between konzo and cyanide
comes essentially from ecological studies and no similar neuro-
damage secondary to exposure from other cyanide sources is
known [57,59]. These limitations need to be taken into account
when considering cyanide toxicity as a cause of konzo.
The presence of high concentrations of unmetabolized lina-
marin in urine in individuals from konzo-affected communities
compared with controls, and the potential of linamarin to induce
neuronal lesions in experiments, support the possibility of
linamarin as a cause of konzo [7,50,51].
AC, a metabolite of linamarin (Figure 2), is present in cassava
flour consumed in association with konzo. As it is labile, its
concentration decreases with time during storage. When an
agricultural crisis results in food shortage, cassava may be
consumed without previous storage, increasing exposure to AC.
In experiments on rats, this metabolite caused selective neuronal
degeneration in different brain areas, including non-cortical areas.
Even considering the obvious limitations of an animal model, this
finding suggests a possible contribution of this metabolite to konzo
neurotoxicity and could help explain the additional non-motor
Figure 3. From poverty to cyanogen intoxication.
doi:10.1371/journal.pntd.0001051.g003
Table 2. Experiments showing cyanogen neurotoxicity.
Subjects/Animals Exposure Relevant Neurotoxic Findings Motor Changes and Similarities to Konzo
Neural phaeochromocytoma
cell culture [50]
Linamarin (acute) Direct linamarin-induced lesion neural
culture
None
Rats on low SAA diet [51] Linamarin (chronic) Structural and functional proteomic
modifications in the spinal cord
Non-motor symptoms; hind limb tremors can occur
transiently at onset of konzo
Rats on low SAA diet [51] Cyanate (chronic) Structural and functional proteomic
modifications in the spinal cord
Motor weakness, gait abnormalities resembling findings
in konzo
Rats [52] Cyanate (Acute) Glutathione depletion by inhibition of
glutathione reductase activity in the brain
None
Rats on low SAA diet [53] Acetone cyanohydrin
(chronic)
Structural brain lesions in nonmotor areas None
Goats [54] Cyanate (chronic) Structural lesions at different levels of the
nervous system (including ventral horn of
the spinal cord and brainstem)
None
Rhesus monkeys [55] Cyanate (chronic) Structural lesions at different levels of the
nervous system (Betz cells in the motor
cortex , basal ganglia, and anterior horn cells)
Sudden onset of irreversible spastic quadriparesis
resembling konzo, in association with general signs
(wasting, anorexia)
SAA, sulphur amino acid.
doi:10.1371/journal.pntd.0001051.t002
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the appearance of disease in this model [53].
The possibility of neurotoxicity by nitriles such as AC is
attractive, as in theory it could unify the pathogenesis of konzo
with two other familiar and similar toxico-nutritional neurological
diseases: lathyrism, a non-progressive bilateral symmetric parapa-
resis associated with consumption of grass pea (Lathyrus sativus), and
TAN, which has been associated with cassava consumption for
many years. In theory, different nitriles present in cassava and
grass pea could cause different direct neurotoxic patterns and/or
different diseases [60].
Excitotoxic damage related to glutathione deficiency in konzo
and lathyrism is also under debate [61]. SAAs such as methionine
are essential for the synthesis of brain glutathione, which is the
most abundant intracellular antioxidant and an important agent
for detoxification of xenobiotics [62]. The absence of the
cytoprotective glutathione, secondary to deficiency of SAA, would
expose the brain to cyanogen neurotoxicity in konzo. Oxidative
stress can be induced by exercise, and levels of glutathione
transiently decrease during physical activity [63,64]. As konzo
often installs during or after exercise, it could be a consequence of
an exacerbation of a chronic state of neuron glutathione
deficiency.
Recently, thiamine deficiency, due to the use of thiamine
sulphur for cyanide detoxification, was proposed as a possible
cause of konzo [65]. Although peripheral neuropathy is sometimes
reported in konzo epidemics, the absence of other typical
manifestations of thiamine deficiency, such as Wernicke enceph-
alopathy, Korsakoff syndrome, or wet beriberi, does not favor this
hypothesis [66,67].
Traditionally, thiocyanate is considered to be an innocuous
product of cyanide detoxification, but some authors have proposed
that it may have an aetiological role in konzo [59].
From Individual Susceptibility to the Clinical
Expression of Konzo
Susceptibility to Konzo
People are not uniformly affected by konzo. Children above the
age of 3 years and women in the fertile age group are more
affected than adult males [1–8].
Many possible reasons can explain these differences. Adult
males are more privileged in terms of finding and eating additional
sources of food. Women and their accompanying children may be
more exposed to cassava cyanide because they eat the toxic fresh
roots, and may have additional exposure from cyanide inhalation
during preparation or storage.
Pregnancy and breast-feeding are additional nutritional stresses
that could predispose women to the toxic effects of cassava [9].
Biological differences, as in other neurological diseases, could
affect susceptibility to cyanogens [68].
Breast-feeding children do not get konzo [1–8]. Studies have
shown that the mammary gland barrier reduces thiocyanate
passage from maternal serum to milk [69,70]. We lack information
about the presence in breast milk of the other candidates for
neurotoxicity under the magnitude of exposure that occurs in
konzo, and with the associated nutritional deficiency. Breast-fed
children are, however, unlikely to be directly exposed to most of
the potentially toxic compounds, as the milk has been processed in
the body of the mother.
Familial clustering of cases of konzo is found in every reported
outbreak. Such clustering does not discriminate between genetic
susceptibility and environmental factors such as socioeconomic
status and food intake. In the case of konzo, the age and gender
distribution is more likely to be explained by common exposure,
than genetic susceptibility.
The Clinical Expression of Konzo
Acute intoxication symptoms due to cyanide include tachy-
pnoea, tachycardia, dizziness, headache, abdominal pain, vomit-
ing, diarrhea, mental confusion, and convulsions, generally 4–6
hours after ingestion of meals containing cassava [58,71–73].
These symptoms are sometimes reported during konzo epidemics
and in acute poisoning cases are attributed to cassava consump-
tion, but without any recognizable motor sequelae [71–73].
The hallmark of konzo is difficulty in walking, and often the
affected person walks with the help of sticks (Figure 4).
Usually, in less than a week, an acute and non-progressive
symmetric spastic paraparesis becomes installed. The disease
sometimes starts during or after manual work or a long walk.
Although it starts abruptly, konzo follows the consumption of a
Figure 4. Children with konzo in a rural area of Mozambique
(faces blurred).
doi:10.1371/journal.pntd.0001051.g004
Figure 5. Different degrees of severity of konzo in children
from Democratic Republic of Congo (faces blurred). Image
Credit: Thorkild Tylleskar.
doi:10.1371/journal.pntd.0001051.g005
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several weeks [6–10].
Transient non-motor symptoms such as paraesthesiae in the
lower limbs, cramping, pain or trembling in the legs, and low back
pain can precede or accompany the paraparesis of konzo, and
disappear in weeks [2,8–10].
Upper limb involvement in konzo varies from impairment of
fine motor function accompanying spastic paraparesis, to a spastic
tetraparesis, preventing autonomous ambulation [8,9,74]. Addi-
tional neurological findings such as optic neuropathy, rotatory
nystagmus, pseudobulbar dysarthria, and hypoacusia are seen in
some cases [6,9,23,75,76].
Signsofuppermotordamage,intheformofspasticityresultingin
exaggerated reflexes, ankle clonus, and extensor plantar reflexes are
clinical markers in the absence of paraparesis. Studies have shown
that the rate of ankle clonus is high in apparently healthy school
children from affected areas 2 years after the epidemics [77].
Depending on its severity, konzo is divided into three categories:
mild when individuals are able to walk without support, moderate
when individuals need one or two sticks to walk, and severe when
the affected person is unable to walk (Figure 5) [10].
Using a comprehensive definition of disease, konzo should
include the complete spectrum of clinical manifestations, ranging
from ‘‘minor’’ isolated signs such as clonus to severe forms with
tetraparesis (Figure 6). The case definition of konzo recommended
by the World Health Organization (WHO) is based on the
combination of visible spastic abnormalities in walking, a history
of sudden onset in a formerly healthy person, and bilaterally
exaggerated knee or ankle jerks without signs of disease of the spine
[10]. By using these criteria, people with clonus and mild spasticity,
but without visible difficulty in walking, are not considered to have
konzo. However, because these minor signs are present in
apparently healthy people [77], and they are only recognizable if
neurological examination is performed, case detection and
comparison between case series would be difficult to carry out.
On general examination, no consistent abnormality is found in
konzo, but signs of malnutrition, anaemia, and splenomegaly may
be present [76].
Second attacks have been reported in around 10% of patients.
Contractures are a commonly developing complication over the
years in more severe cases without physiotherapy, and painful calf
muscle spasm may be a major chronic symptom [9,74,78].
There is no proven treatment for konzo. WHO recommends
dietary diversification and immediate treatment with high doses of
multivitamins, particularly vitamin B, in order to avoid increased
neurodamage due to concurrent vitamin deficiency [10].
There is a lack of consistent studies assessing excess mortality in
konzo, but in Tanzania and DRC, increased death rates were
reported [2,21].
Conclusion and Future Directions
Taking Africa as a whole, konzo may not be a major public
health problem, but for affected communities, the disease is a
major burden. Increasing cassava production, declining produc-
tion of other foods, global warming, more frequent droughts, wars,
and population displacement have set the scene for konzo to
persist.
Early recognition of konzo and active case detection is
important to reveal the real extension of any konzo outbreak.
Figure 6. From individual susceptibility to the spectrum of
konzo.
doi:10.1371/journal.pntd.0001051.g006
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www.plosntds.org 6 June 2011 | Volume 5 | Issue 6 | e1051Local authorities should promptly initiate interventions to avoid
further cases.
Immediate interventions to prevent konzo in affected areas,
such as providing food and vitamins, and promotion and
dissemination of methods such as the wetting method to detoxify
cassava flour in some affected areas, are essential.
In a long-term perspective, other interventions include improv-
ing food diversity and intake through more investment and
support to rural agriculture. Introduction of new low cyanide
cassava varieties that are also high yielding and disease resistant
may also be considered.
Further research is needed on the impact of global warming on
cassava production and cyanogen content. At a local level,
determination of the acceptability on a wider scale of efficient
processing methods is needed. Finally, the pathophysiology of
konzo still needs to be elucidated.
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